Canada markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
1.8800+0.0500 (+2.73%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
71,388
74,779
92,965
101,980
Cost of Revenue
46,350
52,731
54,888
53,400
Gross Profit
25,038
22,048
38,077
48,580
Operating Expenses
Research Development
4,428
4,138
4,497
5,080
Selling General and Administrative
36,072
29,166
24,683
27,499
Total Operating Expenses
40,021
32,964
24,512
30,722
Operating Income or Loss
-14,983
-10,916
13,565
17,858
Interest Expense
10,943
24,670
5,459
5,535
Total Other Income/Expenses Net
-13,843
-5,836
-6,940
-17,776
Income Before Tax
-39,265
-41,194
751
-6,633
Income Tax Expense
-67
-192
-178
-620
Income from Continuing Operations
-39,198
-41,002
929
-6,013
Net Income
-28,596
-41,009
875
-6,388
Net Income available to common shareholders
-28,596
-41,009
875
-6,388
Basic EPS
-0.76
-6.08
0.20
-1.60
Diluted EPS
-0.76
-6.08
0.20
-1.60
Basic Average Shares
38,201
6,747
4,180
4,180
Diluted Average Shares
38,201
6,747
5,326
5,251